Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Pharmacol ; 66(5): 694-704, 2014 May.
Article in English | MEDLINE | ID: mdl-24438047

ABSTRACT

OBJECTIVES: In this study, we evaluated the effect of the proanthocyanidins-rich fraction (PRF) obtained from Croton celtidifolius bark in an experimental animal model of spinal cord injury and cell death induced by glutamate. METHODS: Experiments were conducted using adult male Wistar rats (10 weeks old and weighing 270-300g). Experimental groups were randomly allocated into the following groups: spinal cord injury (SCI) + vehicle group: rats were subjected to SCI plus intraperitoneal administration of vehicle (saline 10 ml/kg); SCI + PRF: rats were subjected to SCI plus intraperitoneal administration of PRF (10 mg/kg) at 1 and 6 h after injury and sham operated. KEY FINDINGS: The treatment with the proanthocyanidin-rich fraction significantly improved not only motor recovery and grip force but also H2 O2 or glutamate-induced cell death and reactive oxygen species generation induced by glutamate in dorsal root ganglion cells. In this study we demonstrate that the neuroprotective effect triggered by the proanthocyanidins-rich fraction appears to be mediated in part by the inhibition of N-methyl-D-aspartate-type glutamate receptors. CONCLUSIONS: Taken together, our results demonstrate that PRF treatment ameliorates spinal cord injury and glutamatergic excitotoxicity and could have a potential therapeutic use.


Subject(s)
Croton/chemistry , Glutamic Acid/adverse effects , Neuroprotective Agents/therapeutic use , Phytotherapy , Proanthocyanidins/therapeutic use , Receptors, Glutamate/metabolism , Spinal Cord Injuries/drug therapy , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Cell Death/drug effects , Disease Models, Animal , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Male , Movement/drug effects , Muscle Strength/drug effects , Neuroprotective Agents/pharmacology , Plant Bark , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Proanthocyanidins/pharmacology , Rats, Wistar , Reactive Oxygen Species/metabolism , Spinal Cord Injuries/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...